Literature DB >> 12709083

Pre-transplant Th1 and post-transplant Th2 cytokine patterns are associated with early acute rejection in renal transplant recipients.

M Sadeghi1, V Daniel, R Weimer, M Wiesel, O Hergesell, G Opelz.   

Abstract

In this retrospective study, we tried to define pre- and post-transplant immunological parameters that identify patients at risk for early acute rejection. Lymphocyte subpopulations and plasma levels of cytokines and neopterin were determined pre- and post-transplant in 32 renal transplant recipients with biopsy-proven early acute graft rejection. Recipients without early acute rejection served as controls. High pre-transplant interferon-gamma (IFN-gamma) plasma levels (p = 0.006), consistently high levels of neopterin early post-transplant (p = 0.008), a post-transplant switch from a Th1 to a Th2 cytokine pattern with decreasing IFN-gamma (p = 0.02), low CD8+ lymphocyte counts (p = 0.006) and consistently high CD19+ B lymphocyte counts were associated with acute rejection. Our data suggest that patients with a pre-transplant Th1 and an early post-transplant Th2 cytokine pattern are pre-disposed for early acute rejection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709083     DOI: 10.1034/j.1399-0012.2003.00037.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  9 in total

1.  Correlation of CD95 and soluble CD95 expression with acute rejection status of liver transplantation.

Authors:  Yu-Liang Wang; Yan-Yan Zhang; Guang Li; Zhi-Qin Tang; Yan-Li Zhou; Zhi-Jun Zhu; Zhi Yao
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

2.  Ischaemic/reperfusion injury: Role of infliximab.

Authors:  Atul Bagul
Journal:  World J Transplant       Date:  2012-06-24

3.  Murine cytomegalovirus promotes renal allograft inflammation via Th1/17 cells and IL-17A.

Authors:  Ravi Dhital; Shashi Anand; Brianna Graber; Qiang Zeng; Victoria M Velazquez; Srinivasa R Boddeda; James R Fitch; Ranjana W Minz; Mukut Minz; Ashish Sharma; Rachel Cianciolo; Masako Shimamura
Journal:  Am J Transplant       Date:  2022-06-15       Impact factor: 9.369

4.  The value of serum neopterin, interferon-gamma levels and interleukin-12B polymorphisms in predicting acute renal allograft rejection.

Authors:  G K Chin; C L Adams; B S Carey; S Shaw; W-Y Tse; E R Kaminski
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

5.  Pretransplant Immune- and Apoptosis-Related Gene Expression Is Associated with Kidney Allograft Function.

Authors:  Dorota Kamińska; Katarzyna Kościelska-Kasprzak; Paweł Chudoba; Oktawia Mazanowska; Mirosław Banasik; Marcelina Żabinska; Maria Boratyńska; Agnieszka Lepiesza; Agnieszka Gomółkiewicz; Piotr Dzięgiel; Marian Klinger
Journal:  Mediators Inflamm       Date:  2016-06-12       Impact factor: 4.711

Review 6.  Old game, new players: Linking classical theories to new trends in transplant immunology.

Authors:  Marina Burgos da Silva; Flavia Franco da Cunha; Fernanda Fernandes Terra; Niels Olsen Saraiva Camara
Journal:  World J Transplant       Date:  2017-02-24

7.  Pre-transplant CD200 and CD200R1 concentrations are associated with post-transplant events in kidney transplant recipients.

Authors:  Hani Oweira; Elias Khajeh; Sara Mohammadi; Omid Ghamarnejad; Volker Daniel; Paul Schnitzler; Mohammad Golriz; Markus Mieth; Christian Morath; Martin Zeier; Arianeb Mehrabi; Mahmoud Sadeghi
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

8.  Influence of pro- and anti-inflammatory cytokines in Th1 polarization after allogeneic stimulation.

Authors:  R Silva; J M Morgado; A Freitas; A Couceiro; A Orfao; F Regateiro; A Paiva
Journal:  Int J Biomed Sci       Date:  2005-06

9.  A shift towards pro-inflammatory CD16+ monocyte subsets with preserved cytokine production potential after kidney transplantation.

Authors:  Elly J F Vereyken; Marina D Kraaij; Carla C Baan; Farhad Rezaee; Willem Weimar; Kathryn J Wood; Pieter J M Leenen; Ajda T Rowshani
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.